hydralazine has been researched along with niacinamide in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (14.29) | 18.7374 |
| 1990's | 5 (35.71) | 18.2507 |
| 2000's | 4 (28.57) | 29.6817 |
| 2010's | 2 (14.29) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Brown, JM; Lemmon, M; Menke, D; Minchinton, AI; Stone, HB | 1 |
| Freeman, D; Hurd, RE | 1 |
| Chaplin, DJ; Horsman, MR; Overgaard, J | 1 |
| Chaplin, DJ; Horsman, MR; Peters, CE; Trotter, MJ | 1 |
| Imai, S; Matsui, K; Ogawa, Y | 1 |
| Greengard, P; Quinn, GP; Reid, MB | 1 |
| Bhujwalla, ZM; Glickson, JD; Shungu, DC | 1 |
| Griffiths, JR; Howe, FA; Robinson, SP; Stubbs, M | 1 |
| Begg, AC; Haustermans, K; Hofland, I; Van Der Pavert, I; Van Der Schueren, B | 1 |
| Chen, B; de Witte, PA; Zupkó, I | 1 |
| Griffiths, JR; Jork, A; Newell, B; Nöth, U; Robinson, SP; Rodrigues, LM; Zimmermann, U | 1 |
| Goto, H; Ishii, Y; Takeuchi, K; Umehara, K; Yamada, H; Yokouchi, C | 1 |
| Goto, H; Hidoh, Y; Ishii, Y; Nishimura, Y; Sato, M; Takeuchi, K; Yokouchi, C | 1 |
1 review(s) available for hydralazine and niacinamide
| Article | Year |
|---|---|
The use of blood flow modifiers to improve the treatment response of solid tumors.
Topics: Animals; Combined Modality Therapy; Hydralazine; Mice; Neoplasms, Experimental; Niacinamide; Pyrazinamide; Regional Blood Flow | 1991 |
13 other study(ies) available for hydralazine and niacinamide
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Pharmacological modification of tumor blood flow: lack of correlation between alteration of mean arterial blood pressure and changes in tumor perfusion.
Topics: Animals; Blood Pressure; Carcinoma, Squamous Cell; Female; Flavonoids; Hydralazine; Mice; Mice, Inbred C3H; Niacinamide; Regional Blood Flow; Tumor Cells, Cultured | 1992 |
Proton editing and imaging of lactate.
Topics: Animals; Hydralazine; Lactates; Lactic Acid; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Mice; Mice, Inbred C3H; Models, Structural; Neoplasms, Experimental; Niacinamide; Protons | 1991 |
Drug induced perturbations in tumor blood flow: therapeutic potential and possible limitations.
Topics: Animals; Cell Hypoxia; Hydralazine; Mice; Neoplasms, Experimental; Niacinamide; Propranolol; Regional Blood Flow | 1991 |
Relaxant effects of pinacidil, nicorandil, hydralazine and nifedipine as studied in the porcine coronary artery and guinea-pig taenia coli.
Topics: Animals; Caffeine; Colon; Coronary Vessels; Female; Guanidines; Guinea Pigs; Hydralazine; In Vitro Techniques; Male; Muscle Relaxation; Muscle, Smooth; Muscle, Smooth, Vascular; Niacinamide; Nicorandil; Nifedipine; Pinacidil; Potassium; Swine; Vasodilator Agents | 1986 |
Prevention by antidepressant drugs of reserpine effect on pyridine nucleotide metabolism.
Topics: Aminopyrine; Amitriptyline; Amphetamine; Animals; Antidepressive Agents; Atropine; Benactyzine; Caffeine; Chlorpheniramine; Chlorpromazine; Female; Hexobarbital; Hydralazine; Hypothalamus; Imipramine; Iproniazid; Isoniazid; Liver; Meprobamate; Methacholine Compounds; Morphine; NAD; Niacinamide; Pargyline; Pentobarbital; Phenylbutazone; Phenytoin; Quinacrine; Rats; Reserpine; Tranylcypromine; Tripelennamine; Zoxazolamine | 1966 |
Effects of blood flow modifiers on tumor metabolism observed in vivo by proton magnetic resonance spectroscopic imaging.
Topics: Animals; Antihypertensive Agents; Glycerylphosphorylcholine; Hydralazine; Magnetic Resonance Spectroscopy; Mice; Mice, Inbred C3H; Neoplasms, Experimental; Niacinamide; Oxygen Consumption; Phosphorylcholine; Regional Blood Flow | 1996 |
Effects of nicotinamide and carbogen on tumour oxygenation, blood flow, energetics and blood glucose levels.
Topics: Animals; Blood Glucose; Carbon Dioxide; Energy Metabolism; Female; Hydralazine; Magnetic Resonance Imaging; Niacinamide; Oxygen; Prolactinoma; Rats; Rats, Inbred WF; Time Factors | 2000 |
Use of thymidine analogues to indicate vascular perfusion in tumours.
Topics: Animals; Blood Flow Velocity; Female; Flow Cytometry; Hydralazine; Idoxuridine; Image Processing, Computer-Assisted; Immunohistochemistry; Mice; Mice, Inbred C3H; Neovascularization, Pathologic; Niacinamide; Sarcoma, Experimental; Vasodilator Agents | 2000 |
Photodynamic therapy with hypericin in a mouse P388 tumor model: vascular effects determine the efficacy.
Topics: Animals; Anthracenes; Blood Vessels; Dose-Response Relationship, Drug; Female; Fluorescein; Hydralazine; Injections, Intravenous; Lymphoma; Mice; Mice, Inbred DBA; Niacinamide; Oxygen; Perylene; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms; Vasodilator Agents | 2001 |
In vivo determination of tumor oxygenation during growth and in response to carbogen breathing using 15C5-loaded alginate capsules as fluorine-19 magnetic resonance imaging oxygen sensors.
Topics: Alginates; Animals; Carbon Dioxide; Cell Hypoxia; Crown Ethers; Fluorine; Glucuronic Acid; Hexuronic Acids; Hydralazine; Magnetic Resonance Imaging; Neoplasms; Niacinamide; Oxygen; Partial Pressure; Radiation-Sensitizing Agents; Rats; Rats, Inbred WF; Vasodilator Agents | 2004 |
Alleviation of fatty liver in a rat model by enhancing N
Topics: Aldehyde Oxidase; Animals; Biological Availability; Cytosol; Disease Models, Animal; Enzyme Inhibitors; Female; Humans; Hydralazine; Inhibitory Concentration 50; Liver; Liver Cirrhosis; Male; Niacinamide; Nicotinamide N-Methyltransferase; Rats, Sprague-Dawley | 2018 |
Reduction of fatty liver in rats by nicotinamide via the regeneration of the methionine cycle and the inhibition of aldehyde oxidase.
Topics: Administration, Oral; Aldehyde Oxidase; Animals; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Enzyme Inhibitors; Hydralazine; Lipid Droplets; Liver; Male; Methionine; Niacinamide; Non-alcoholic Fatty Liver Disease; Rats, Sprague-Dawley; S-Adenosylmethionine; Triglycerides | 2021 |